ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,618, issued on Feb. 17, was assigned to TANDEM DIABETES CARE INC. (San Diego).

"System and method for mitigating risk in automated medicament dosing" was invented by Sean Saint (San Diego) and Michael Rosinko (Anaheim, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A portable infusion pump can communicate with glucose monitor, such as a continuous glucose monitor (CGM), to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin. Due to potential unreliability in the correlation of th...